Automated detection of potential drug-drug interactions among patients with psychiatric disorders in a teaching hospital in Iran

نویسندگان

1 دانشگاه تهران

2 دانشگاه آزاد اسلامی

3 دانشگاه آزاد اسلامی

4 دانشگاه صنعتی سهند

5 دانشگاه شیراز

6

doi
10.48307/iahsj.2024.425407.1090
چکیده

Objectives: Patients with psychiatric disorders are particularly vulnerable to drug-drug interactions (DDIs), which can lead to significant fluctuations in blood concentrations of medications. This study aimed to assess the prevalence of potential DDIs (pDDIs) in prescriptions made by physicians using a straightforward software tool. Methods: This cross-sectional study was conducted in two phases. The first phase focused on creating a comprehensive database of drug-drug interactions related to psychiatric medications. The second phase involved identifying potential DDIs using SQL Server and Python (version 3.8). Results: A total of 3,107 patients' prescriptions were analyzed, comprising 1,752 men (56.4%) and 1,355 women (43.6%). The average age of participants was 38.95 years (SD = 15.244), with an average length of hospital stay of 12.01 days (SD = 8.756). The majority of patients were diagnosed with mood disorders (n = 1,461; 47.0%). In total, 89,801 prescriptions were evaluated, revealing a prevalence of pDDIs at 34.46% (n = 30,953). Notably, male patients exhibited a higher risk for developing pDDIs. The most frequently encountered pDDIs were associated with mental retardation (55.93%) and mental and behavioral disorders (49.03%). The combinations of Clonazepam with Risperidone (11.93%), Lorazepam with Risperidone (6.87%), and Haloperidol with Lorazepam (6.58%) were identified as the most common pDDIs. In terms of risk classification, the majority fell into class C (n = 24,914; 80.49%), followed by class D (n = 6,033; 19.49%) and class E (n = 6; 0.02%). Conclusion: The findings of this study highlight the urgent need for greater awareness of potential drug-drug interactions among healthcare providers treating psychiatric patients. Implementing computerized prescription screening tools could significantly aid in identifying pDDIs and mitigating the risk of adverse events.